Abstract:The dopaminergic system is susceptible to dysfunction in numerous neurological diseases, including Parkinson's disease (PD). In addition to motor symptoms, some PD patients may experience non-motor symptoms, including cognitive and memory deficits. A possible explanation for their manifestation is a disturbed pattern of dopamine release in brain regions involved in learning and memory, such as the hippocampus. Therefore, investigating neuropathological alterations in dopamine release prior to neurodegeneration is imperative. This study aimed to characterize evoked hippocampal dopamine release and assess the impact of the neurotoxin MPP + using a genetically encoded dopamine sensor and gene expression analysis. Additionally, considering the potential neuroprotective attributes demonstrated by apoptosis signal-regulating kinase 1 ( Ask1 ) in various animal-disease-like models, the study also aimed to determine whether Ask1 knockdown restores MPP + -altered dopamine release in acute hippocampal slices. We applied variations of low- and high-frequency stimulation to evoke dopamine release within different hippocampal regions and discovered that acute application of MPP + reduced the amount of dopamine released and hindered the recovery of dopamine release after repeated stimulation. In addition, we observed that Ask1 deficiency attenuated the detrimental effects of MPP + on the recovery of dopamine release after repeated stimulation. RNA sequencing analysis indicated that genes associated with the synaptic pathways are involved in response to MPP + exposure. Notably, Ask1 deficiency was found to downregulate the expression of Slc5a7 , a gene encoding a sodium-dependent high-affinity choline transporter that regulates acetylcholine levels. Respective follow-up experiments indicated that Slc5a7 plays a role in Ask1 deficiency-mediated protection against MPP + neurotoxicity. In addition, increasing acetylcholine levels using an acetylcholinesterase inhibitor could exacerbate the toxicity of MPP + . In conclusion, our data imply that the modulation of the dopamine-acetylcholine balance may be a crucial mechanism of action underlying the neuroprotective effects of Ask1 deficiency in PD.

Apoptosis signal-regulating kinase 1 (Ask1) deficiency alleviates MPP+-induced impairment of evoked dopamine release in the mouse hippocampus

Gene Expression Profiling of MPP+-treated MN9D Cells: A Mechanism of Toxicity Study

Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation

Downregulation of DEC1 Contributes to the Neurotoxicity Induced by MPP+ by Suppressing PI3K/Akt/GSK3β Pathway

Inhibitor of apoptosis stimulating protein of p53 protects against MPP+-induced neurotoxicity of dopaminergic neurons

DLP1-dependent Mitochondrial Fragmentation Mediates 1-Methyl-4-phenylpyridinium Toxicity in Neurons: Implications for Parkinson's Disease.

The Deficiency of Maged1 Attenuates Parkinson's Disease Progression in Mice

P1‐210: DAPK1 IS REQUIRED FOR THE EARLY NEURONAL DAMAGE AND COGNITIVE IMPAIRMENT INDUCED BY Aβ OLIGOMERS

Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice

The Role of Endophilin A1 in Lipopolysaccharide-Induced Parkinson's Disease Model Mice

MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer's disease models.

Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson’s disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy

Blocking of canonical Notch signaling in dopaminergic neurons prevents its loss induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

DDAH-1 Maintains Endoplasmic Reticulum-Mitochondria Contacts and Protects Dopaminergic Neurons in Parkinson’s Disease

Asparagine endopeptidase deletion ameliorates cognitive impairments by inhibiting proinflammatory microglial activation in MPTP mouse model of Parkinson disease

Knockdown of Long Non-Coding RNA AL049437 Mitigates MPP+ -Induced Neuronal Injury in SH-SY5Y Cells Via the Microrna-205-5p/mapk1 Axis.

DDAH-1 maintains endoplasmic reticulum-mitochondria contacts and protects dopaminergic neurons in Parkinson's disease

Echinacoside Protects Against Mpp+-Induced Neuronal Apoptosis Via Ros/Atf3/Chop Pathway Regulation

NEAT1 enhances MPP+‐induced pyroptosis in a cell model of Parkinson's disease via targeting miR‐5047/YAF2 signaling

Adenosine Monophosphate-Activated Protein Kinase Activation Enhances Embryonic Neural Stem Cell Apoptosis in a Mouse Model of Amyotrophic Lateral Sclerosis

Impaired Mitochondrial Biogenesis Contributes to Depletion of Functional Mitochondria in Chronic MPP+ Toxicity: Dual Roles for ERK1/2